Scopio's advanced cell imaging unveiled by Beckman Coulter
9 Aug 2023
In this video, Beckman Coulter presents how Scopio revolutionizes cell diagnosis for hematological disorders. It enables imaging of tens of thousands of cells simultaneously, transforming cell observation. Scopio's capabilities include cell detection, pre-classification, and quantification, enhancing workflow efficiency and bolstering clinical decision-making with confidence.
About the company
Beckman Coulter Diagnostics
Beckman Coulter, Inc., based in Orange County, California, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world, supplying critical information for improving patient health and reducing the cost of care. Recurring revenue, consisting of supplies, test kits, service and operating-type lease payments, represents approximately 78 percent of the company s 2007 annual revenue of $2.76 billion. For more information, visit www.beckmancoulter.com.
